Literature DB >> 27796187

Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology.

Thomas Dirschka1, Girish Gupta2, Giuseppe Micali3, Eggert Stockfleth4, Nicole Basset-Séguin5, Véronique Del Marmol6, Reinhard Dummer7, Gregor B E Jemec8, Josep Malvehy9,10, Ketty Peris11, Susana Puig9,10, Alexander J Stratigos12, Iris Zalaudek13, Giovanni Pellacani14.   

Abstract

Actinic keratosis (AK) is a chronic skin disease in which multiple clinical and subclinical lesions co-exist across large areas of sun-exposed skin, resulting in field cancerisation. Lesions require treatment because of their potential to transform into invasive squamous cell carcinoma. This article aims to provide office-based dermatologists and general practitioners with simple guidance on AK treatment in daily clinical practice to supplement existing evidence-based guidelines. Novel aspects of the proposed treatment algorithm include differentiating patients according to whether they have isolated scattered lesions, lesions clustered in small areas or large affected fields without reference to specific absolute numbers of lesions. Recognising that complete lesion clearance is rarely achieved in real-life practice and that AK is a chronic disease, the suggested treatment goals are to reduce the number of lesions, to achieve long-term disease control and to prevent disease progression to invasive squamous cell carcinoma. In the clinical setting, physicians should select AK treatments based on local availability, and the presentation and needs of their patients. The proposed AK treatment algorithm is easy-to-use and has high practical relevance for real-life, office-based dermatology.

Entities:  

Keywords:  5-fluorouracil; Diclofenac; field cancerisation; imiquimod; ingenol mebutate; photodynamic therapy

Mesh:

Substances:

Year:  2016        PMID: 27796187     DOI: 10.1080/09546634.2016.1254328

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  20 in total

Review 1.  Cutaneous toxicities of new treatments for melanoma.

Authors:  A Boada; C Carrera; S Segura; H Collgros; P Pasquali; D Bodet; S Puig; J Malvehy
Journal:  Clin Transl Oncol       Date:  2018-05-24       Impact factor: 3.405

2.  Attitudes among dermatologists regarding actinic keratosis treatment options.

Authors:  Gaia Moretta; Tonia Samela; Francesca Sampogna; Francesco Ricci; Fabio Carlesimo; Annarita Panebianco; Angelo Massimiliano D'Erme; Giovanni Di Lella; Sabatino Pallotta; Elena Dellambra; Damiano Abeni; Luca Fania
Journal:  Dermatol Reports       Date:  2022-01-31

3.  Approaches to Field Therapy for Actinic Keratoses: Relating Clinical Trial Results to Real-world Practice-A Commentary.

Authors:  David M Pariser
Journal:  J Clin Aesthet Dermatol       Date:  2022-04

Review 4.  Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches.

Authors:  Zafer Sattouf; Steven J Repas; Jeffrey B Travers; Craig A Rohan
Journal:  J Skin Cancer       Date:  2021-06-19

5.  Clinical Pharmacokinetics and Safety of a 10% Aminolevulinic Acid Hydrochloride Nanoemulsion Gel (BF-200 ALA) in Photodynamic Therapy of Patients Extensively Affected With Actinic Keratosis: Results of 2 Maximal Usage Pharmacokinetic Trials.

Authors:  Ben Novak; Janet DuBois; Osama Chahrour; Tamara Papusha; Stefan Hirt; Thomas Philippi; Corinna Zogel; Katharina Osenberg; Beate Schmitz; Hermann Lübbert
Journal:  Clin Pharmacol Drug Dev       Date:  2021-10-11

6.  Treatment of Grade II and III Actinic Keratosis Lesions with a Film-Forming Medical Device Containing Sunscreen/Piroxicam 0.8% and a Retinoic Acid/Glycolic Gel: A Pilot Trial.

Authors:  Mario Puviani; Massimo Milani
Journal:  Dermatol Ther (Heidelb)       Date:  2018-05-31

Review 7.  Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice.

Authors:  Nevena Skroza; Nicoletta Bernardini; Ilaria Proietti; Concetta Potenza
Journal:  Ther Clin Risk Manag       Date:  2018-10-04       Impact factor: 2.423

8.  Efficacy Endpoints in Clinical Trials in Actinic Keratosis.

Authors:  Torsten Skov; Eggert Stockfleth; Rolf-Markus Szeimies; Brian Berman
Journal:  Dermatol Ther (Heidelb)       Date:  2018-06-18

9.  Systematic Literature Review and Network Meta-analysis of the Efficacy and Acceptability of Interventions in Actinic Keratoses.

Authors:  Khaled Ezzedine; Caroline Painchault; Melanie Brignone
Journal:  Acta Derm Venereol       Date:  2021-01-04       Impact factor: 3.875

10.  The effect of wool hydrolysates on squamous cell carcinoma cells in vitro. Possible implications for cancer treatment.

Authors:  Tatsiana Damps; Anna Katarzyna Laskowska; Tomasz Kowalkowski; Monika Prokopowicz; Anna Katarzyna Puszko; Piotr Sosnowski; Joanna Czuwara; Marek Konop; Krzysztof Różycki; Joanna Karolina Borkowska; Aleksandra Misicka; Lidia Rudnicka
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.